// App-Quantinova.ai

P485 : Real-world evidence (RWE) on outcomes and clinical treatment patterns of 5-aminosalicylic acid (5-ASA) in mild Crohn’s disease (CD) from European healthcare databases (the CROHN’S investigation)

Researchers

Presenter

  • K Paridaens

Principal Investigators

  • Y L Yip

  • O Ghatnekar

  • M Plassais

  • J Edwards

  • J Kuiper

  • B Rodgers-Grey

  • S Buchan

Medical Centers

  • Ferring International Center, St-Prex, Switzerl

  • Ferring International PharmaScience Center, Copenhagen, Denmark

  • Strategen Ltd., Basingstoke, UK

  • PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands

Locations

  • Switzerland

  • Denmark

  • United Kingdom

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Mesalamine

Outcome

  • N/A

Study Design

  • Observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved